1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Niraparib (Zejula) 1.2.3 Olaparib (Lynparza) 1.2.4 Rucaparib (Rubraca) 1.2.5 Talazoparib (Talzenna) 1.3 Market by Application 1.3.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Perspective (2016-2027) 2.2 Enzyme Poly ADP Ribose Polymerase Inhibitor Growth Trends by Regions 2.2.1 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Enzyme Poly ADP Ribose Polymerase Inhibitor Historic Market Share by Regions (2016-2021) 2.2.3 Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Regions (2022-2027) 2.3 Enzyme Poly ADP Ribose Polymerase Inhibitor Industry Dynamic 2.3.1 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Trends 2.3.2 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Drivers 2.3.3 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Challenges 2.3.4 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players by Revenue 3.1.1 Global Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players by Revenue (2016-2021) 3.1.2 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Players (2016-2021) 3.2 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue 3.4 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Concentration Ratio 3.4.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in 2020 3.5 Enzyme Poly ADP Ribose Polymerase Inhibitor Key Players Head office and Area Served 3.6 Key Players Enzyme Poly ADP Ribose Polymerase Inhibitor Product Solution and Service 3.7 Date of Enter into Enzyme Poly ADP Ribose Polymerase Inhibitor Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Enzyme Poly ADP Ribose Polymerase Inhibitor Breakdown Data by Type 4.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Historic Market Size by Type (2016-2021) 4.2 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Type (2022-2027) 5 Enzyme Poly ADP Ribose Polymerase Inhibitor Breakdown Data by Application 5.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Historic Market Size by Application (2016-2021) 5.2 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (2016-2027) 6.2 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type 6.2.1 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) 6.2.2 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) 6.2.3 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2027) 6.3 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application 6.3.1 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) 6.3.2 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) 6.3.3 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2027) 6.4 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country 6.4.1 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) 6.4.2 North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (2016-2027) 7.2 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type 7.2.1 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) 7.2.2 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) 7.2.3 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2027) 7.3 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application 7.3.1 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) 7.3.2 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) 7.3.3 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2027) 7.4 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country 7.4.1 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) 7.4.2 Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (2016-2027) 8.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type 8.2.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2027) 8.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application 8.3.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2027) 8.4 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Region 8.4.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (2016-2027) 9.2 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type 9.2.1 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) 9.2.2 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) 9.2.3 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2027) 9.3 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application 9.3.1 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) 9.3.2 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) 9.3.3 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2027) 9.4 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country 9.4.1 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) 9.4.2 Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (2016-2027) 10.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type 10.2.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2027) 10.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application 10.3.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2027) 10.4 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country 10.4.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.1.4 AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.2.4 Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Takeda 11.3.1 Takeda Company Details 11.3.2 Takeda Business Overview 11.3.3 Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.3.4 Takeda Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.3.5 Takeda Recent Development 11.4 Abbvie 11.4.1 Abbvie Company Details 11.4.2 Abbvie Business Overview 11.4.3 Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.4.4 Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.4.5 Abbvie Recent Development 11.5 Clovis 11.5.1 Clovis Company Details 11.5.2 Clovis Business Overview 11.5.3 Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.5.4 Clovis Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.5.5 Clovis Recent Development 11.6 BeiGene 11.6.1 BeiGene Company Details 11.6.2 BeiGene Business Overview 11.6.3 BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.6.4 BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.6.5 BeiGene Recent Development 11.7 Hansoh 11.7.1 Hansoh Company Details 11.7.2 Hansoh Business Overview 11.7.3 Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.7.4 Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.7.5 Hansoh Recent Development 11.8 Jeil 11.8.1 Jeil Company Details 11.8.2 Jeil Business Overview 11.8.3 Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.8.4 Jeil Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.8.5 Jeil Recent Development 11.9 Oncology 11.9.1 Oncology Company Details 11.9.2 Oncology Business Overview 11.9.3 Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.9.4 Oncology Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.9.5 Oncology Recent Development 11.10 Shin Poong 11.10.1 Shin Poong Company Details 11.10.2 Shin Poong Business Overview 11.10.3 Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Introduction 11.10.4 Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) 11.10.5 Shin Poong Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Niraparib (Zejula) Table 3. Key Players of Olaparib (Lynparza) Table 4. Key Players of Rucaparib (Rubraca) Table 5. Key Players of Talazoparib (Talzenna) Table 6. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Regions (2016-2021) Table 10. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Regions (2022-2027) Table 12. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Trends Table 13. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Drivers Table 14. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Challenges Table 15. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Restraints Table 16. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Players (2016-2021) Table 18. Global Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor as of 2020) Table 19. Ranking of Global Top Enzyme Poly ADP Ribose Polymerase Inhibitor Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Enzyme Poly ADP Ribose Polymerase Inhibitor Product Solution and Service Table 23. Date of Enter into Enzyme Poly ADP Ribose Polymerase Inhibitor Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 26. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Type (2016-2021) Table 27. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Application (2016-2021) Table 31. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 34. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 36. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 63. AstraZeneca Company Details Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 66. AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 67. AstraZeneca Recent Development Table 68. Pfizer Company Details Table 69. Pfizer Business Overview Table 70. Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 71. Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 72. Pfizer Recent Development Table 73. Takeda Company Details Table 74. Takeda Business Overview Table 75. Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 76. Takeda Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 77. Takeda Recent Development Table 78. Abbvie Company Details Table 79. Abbvie Business Overview Table 80. Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 81. Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 82. Abbvie Recent Development Table 83. Clovis Company Details Table 84. Clovis Business Overview Table 85. Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 86. Clovis Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 87. Clovis Recent Development Table 88. BeiGene Company Details Table 89. BeiGene Business Overview Table 90. BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 91. BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 92. BeiGene Recent Development Table 93. Hansoh Company Details Table 94. Hansoh Business Overview Table 95. Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 96. Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 97. Hansoh Recent Development Table 98. Jeil Company Details Table 99. Jeil Business Overview Table 100. Jeil Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 101. Jeil Recent Development Table 102. Oncology Company Details Table 103. Oncology Business Overview Table 104. Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 105. Oncology Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 106. Oncology Recent Development Table 107. Shin Poong Company Details Table 108. Shin Poong Business Overview Table 109. Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Product Table 110. Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) & (US$ Million) Table 111. Shin Poong Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type: 2020 VS 2027 Figure 2. Niraparib (Zejula) Features Figure 3. Olaparib (Lynparza) Features Figure 4. Rucaparib (Rubraca) Features Figure 5. Talazoparib (Talzenna) Features Figure 6. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Enzyme Poly ADP Ribose Polymerase Inhibitor Report Years Considered Figure 11. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Regions: 2020 VS 2027 Figure 14. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Regions (2022-2027) Figure 15. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Players in 2020 Figure 16. Global Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enzyme Poly ADP Ribose Polymerase Inhibitor as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in 2020 Figure 18. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Type (2016-2021) Figure 19. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Type (2022-2027) Figure 20. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type (2016-2027) Figure 22. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application (2016-2027) Figure 23. North America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Country (2016-2027) Figure 24. United States Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type (2016-2027) Figure 28. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application (2016-2027) Figure 29. Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Country (2016-2027) Figure 30. Germany Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type (2016-2027) Figure 38. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application (2016-2027) Figure 39. Asia-Pacific Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Region (2016-2027) Figure 40. China Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type (2016-2027) Figure 48. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application (2016-2027) Figure 49. Latin America Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Country (2016-2027) Figure 50. Mexico Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Type (2016-2027) Figure 54. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Application (2016-2027) Figure 55. Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Market Share by Country (2016-2027) Figure 56. Turkey Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. AstraZeneca Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 61. Takeda Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 62. Abbvie Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 63. Clovis Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 64. BeiGene Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 65. Hansoh Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 66. Jeil Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 67. Oncology Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 68. Shin Poong Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase Inhibitor Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

AstraZeneca Pfizer Takeda Abbvie Clovis BeiGene Hansoh Jeil Oncology Shin Poong